Erudio Healtherudio.com
Drug
Opevesostat trials: what clinicians said in public
HCP commentary reports on 2 clinical trials studying opevesostat: OMAHA-003 and OMAHA-004. Each covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| OMAHA-003 NCT06136624 · Merck Sharp & Dohme LLC | mCRPC after NHA and taxane-based chemotherapy | Phase 3 | 47 | 8 | Focused | Nov 15, 2026 | Preview |
| OMAHA-004 NCT06136650 · Merck Sharp & Dohme LLC | metastatic castration-resistant prostate cancer post one NHA | Phase 3 | 72 | 7 | Focused | Nov 15, 2026 | Preview |